Drawing for STIMUMAB

USPTO serial 76346875

STIMUMAB

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
CASE, LEIGH CAROLINE
Law office
TMEG LAW OFFICE 105 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with STIMUMAB?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Leslye B. Davidson

LESLYE B DAVIDSON DAVIDSON, DAVIDSON & KAPPEL, LLC485 SEVENTH AVENEW YORK, NY 10018UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical compositions for stimulating an immune response or for tumor therapyACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
May 20, 2005MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
May 20, 2005ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Oct 22, 2004CNSIINQUIRY AS TO SUSPENSION MAILED—
Oct 21, 2004CNSISUSPENSION INQUIRY WRITTEN—
Sep 9, 2004RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Apr 9, 2004CNSLLETTER OF SUSPENSION MAILED—
Jan 13, 2004CFITCASE FILE IN TICRS—
Dec 29, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 29, 2003MAILPAPER RECEIVED—
Dec 23, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 27, 2003CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 21, 2002CNSLLETTER OF SUSPENSION MAILED—
Jul 29, 2002CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 29, 2002MAILPAPER RECEIVED—
Mar 8, 2002CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 26, 2002DOCKASSIGNED TO EXAMINER—
Feb 21, 2002DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance